Michael L. Blum

Insider Reports History

Entity
Individual
Location
C/O Homology Medicines, Inc., 45 Wiggins Avenue, Bedford, MA
Signature
/s/ Paul Alloway, Attorney-in-Fact for Michael L. Blum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael L. Blum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Chief Commercial Officer Employee Stock Option (Right to Buy) 104K $1.4M $13.42 Feb 23, 2023 Direct
Homology Medicines, Inc. Chief Commercial Officer Restricted Stock Units 17K $19.6K $1.15 Feb 23, 2023 Direct

Insider Reports Filed by Michael L. Blum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FIXX Homology Medicines, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Chief Commercial Officer
FIXX Homology Medicines, Inc. Jan 9, 2023 0 $0 4/A Jan 20, 2023 Chief Commercial Officer
FIXX Homology Medicines, Inc. Jan 1, 2023 4 $0 4 Jan 4, 2023 Chief Commercial Officer
FIXX Homology Medicines, Inc. Mar 2, 2022 0 $0 3/A Jan 20, 2023 Chief Commercial Officer